Eric Weinberg Biography and Net Worth

Insider of RxSight

Mr. Weinberg has served as our Chief Commercial Officer since June 2015. Prior to joining RxSight, he was a co-founder of LenSx Lasers, Inc. and served as Chief Commercial Officer from July 2008 to August 2010, prior to its acquisition by Alcon Inc. (NYSE:ALC). He went on to serve as Vice President of Surgical Development at Alcon LenSx, Inc. from August 2010 to April 2014. He joined IntraLase Corp. (NASDAQ:ILSE) in September 1999 as Vice President of Sales and Marketing and later as the Senior Vice President, Global Marketing until the company was acquired by Advanced Medical Optics, Inc. (NYSE:EYE) in April 2007. Mr. Weinberg served as Global Director of Refractive Surgery at Chiron Vision Corp. from March 1993 until October 1997, when it was acquired by Bausch & Lomb, Inc. He continued as Global Director of Refractive Surgery at Bausch & Lomb until August 1999. Mr. Weinberg began his career in medical devices at Steinway Instruments in 1980.

What is Eric Weinberg's net worth?: The estimated net worth of Eric Weinberg is at least $4.22 million as of February 1st, 2024. Weinberg owns 299,978 shares of RxSight stock worth more than $4,223,690 as of April 13th. This net worth evaluation does not reflect any other assets that Weinberg may own. Additionally, Weinberg receives a salary of $762,740.00 as Insider at RxSight. Learn More about Eric Weinberg's net worth.
How old is Eric Weinberg?: Weinberg is currently 63 years old. There are 3 older executives and no younger executives at RxSight. The oldest executive at RxSight is Ms. Shelley B. Thunen, Chief Financial Officer, who is 70 years old. Learn More on Eric Weinberg's age.
What is Eric Weinberg's salary?: As the Insider of RxSight, Inc., Weinberg earns $762,740.00 per year. The highest earning executive at RxSight is Dr. Ronald M. Kurtz M.D., President, CEO & Director, who commands a salary of $1,210,000.00 per year. Learn More on Eric Weinberg's salary.
How do I contact Eric Weinberg?: The corporate mailing address for Weinberg and other RxSight executives is , , . RxSight can also be reached via phone at 949-521-7830 and via email at ir@rxsight.com. Learn More on Eric Weinberg's contact information.
Has Eric Weinberg been buying or selling shares of RxSight?: Eric Weinberg has not been actively trading shares of RxSight within the last three months. Most recently, Eric Weinberg sold 10,000 shares of the business's stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $50.00, for a transaction totalling $500,000.00. Following the completion of the sale, the insider now directly owns 299,978 shares of the company's stock, valued at $14,998,900. Learn More on Eric Weinberg's trading history.
Who are RxSight's active insiders?: RxSight's insider roster includes Julie Andrews (Director), Juliet Bakker (Director), Jesse Corley (Director), Tamara Fountain (Director), Ilya Goldshleger (Insider), Ilya Goldshleger (Insider), M Kurtz (CEO), William Link (Director), Shweta Maniar (Director), Shelley Thunen (CFO), Robert Warner (Director), and Eric Weinberg (Insider). Learn More on RxSight's active insiders.
Are insiders buying or selling shares of RxSight?: In the last year, RxSight insiders bought shares 2 times. They purchased a total of 12,554 shares worth more than $549,098.81. In the last year, insiders at the sold shares 28 times. They sold a total of 160,951 shares worth more than $8,269,376.44. The most recent insider tranaction occured on March, 12th when Director Tamara Fountain sold 7,000 shares worth more than $179,970.00. Insiders at RxSight own 9.4% of the company. Learn More about insider trades at RxSight.
Information on this page was last updated on 3/12/2025.

Eric Weinberg Insider Trading History at RxSight

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2024	Sell	10,000	$50.00	$500,000.00	299,978
1/22/2024	Sell	10,000	$48.00	$480,000.00	309,978
1/8/2024	Sell	10,000	$42.00	$420,000.00	329,978
12/22/2023	Sell	1,285	$40.00	$51,400.00	339,978
12/15/2023	Sell	8,715	$40.01	$348,687.15	341,263

Eric Weinberg Buying and Selling Activity at RxSight

RxSight Company Overview

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Today's Range

Now: $14.08

$13.50

$14.56

50 Day Range

MA: $25.63

$14.08

$34.26

2 Week Range

Now: $14.08

$13.50

$66.54

Volume

1,102,327 shs

Average Volume

603,910 shs

Market Capitalization

$570.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Eric Weinberg Biography and Net Worth

What is Eric Weinberg's net worth?

How old is Eric Weinberg?

What is Eric Weinberg's salary?

How do I contact Eric Weinberg?

Has Eric Weinberg been buying or selling shares of RxSight?

Who are RxSight's active insiders?

Are insiders buying or selling shares of RxSight?